Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q8VDM6

Entry ID Method Resolution Chain Position Source
AF-Q8VDM6-F1 Predicted AlphaFoldDB

50 variants for Q8VDM6

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3388894329 114 P>S No EVA
rs3388892595 145 E>K No EVA
rs3388886078 162 L>P No EVA
rs3388888582 190 D>G No EVA
rs3388886103 216 T>I No EVA
rs3388892615 230 S>N No EVA
rs3388890903 250 S>N No EVA
rs3388877400 284 R>G No EVA
rs3397704982 298 E>K No EVA
rs3397685410 300 P>A No EVA
rs3397685393 301 F>L No EVA
rs3397677614 303 Y>* No EVA
rs3397439035 305 Y>* No EVA
rs3388889881 329 V>A No EVA
rs3388886041 332 C>Y No EVA
rs3388873520 361 K>R No EVA
rs3388883151 380 V>A No EVA
rs3388877455 382 F>I No EVA
rs3388883046 401 I>V No EVA
rs3388888524 408 E>V No EVA
rs3388889918 421 E>D No EVA
rs3388877410 432 A>G No EVA
rs3388864584 525 F>L No EVA
rs3388886034 536 D>V No EVA
rs3388881340 559 V>F No EVA
rs3388886235 590 K>E No EVA
rs3388870440 606 P>L No EVA
rs3388894355 608 K>R No EVA
rs232727561 612 S>N No EVA
rs3388892172 645 R>P No EVA
rs3388886031 647 G>C No EVA
rs220240422 651 S>G No EVA
rs3397677657 667 G>C No EVA
rs3397677677 670 Y>H No EVA
rs237236220 690 N>S No EVA
rs3388849750 724 R>Q No EVA
rs3388870486 731 S>C No EVA
rs3388888517 743 A>S No EVA
rs3388892214 746 S>C No EVA
rs13461779 754 T>S No EVA
rs3388892169 756 P>L No EVA
rs3388894304 770 Y>N No EVA
rs3388886056 782 P>T No EVA
rs3397284319 800 Y>H No EVA
rs3397750866 815 S>I No EVA
rs3397615442 816 Y>* No EVA
rs3396912120 821 Q>L No EVA
rs3388888518 837 P>A No EVA
rs3388864550 839 Y>* No EVA
rs3388883177 858 T>A No EVA

No associated diseases with Q8VDM6

4 regional properties for Q8VDM6

Type Name Position InterPro Accession
domain B30.2/SPRY domain 192 - 389 IPR001870
domain SAP domain 3 - 37 IPR003034
domain SPRY domain 255 - 388 IPR003877
domain Heterogeneous nuclear ribonucleoprotein U, SPRY domain 212 - 389 IPR035778

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
ribonucleoprotein complex A macromolecular complex that contains both RNA and protein molecules.

2 GO annotations of molecular function

Name Definition
enzyme binding Binding to an enzyme, a protein with catalytic activity.
RNA binding Binding to an RNA molecule or a portion thereof.

2 GO annotations of biological process

Name Definition
response to virus Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a virus.
RNA processing Any process involved in the conversion of one or more primary RNA transcripts into one or more mature RNA molecules.

2 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q00839 HNRNPU Heterogeneous nuclear ribonucleoprotein U Homo sapiens (Human) PR
Q9BUJ2 HNRNPUL1 Heterogeneous nuclear ribonucleoprotein U-like protein 1 Homo sapiens (Human) PR
10 20 30 40 50 60
MDVRRLKVNE LREELQRRGL DTRGLKAELA ERLLAALEAE EPEDERELEA DDDPGLPGHN
70 80 90 100 110 120
NEEVETEGGS ELEGTAQPPP PGLQPHPEPG GYSGPDGHYV MDNITRQNQF YETPVIKQEN
130 140 150 160 170 180
ESSYDRRPLD MEPQQQVYHP ELKTEMKQEA PPSFLPPEAS QLKTDRPQFQ NRKRPFEENR
190 200 210 220 230 240
GRGYFEHRED RRGRSPQPPA EEDEDDFDDT LVAIDTYNCD LHFKVARDRS SGYPLTIEGF
250 260 270 280 290 300
AYLWSGARAS YGVRRGRVCF EMKINEEISV KHLPSTEPDP HVVRIGWSLD SCSTQLGEEP
310 320 330 340 350 360
FSYGYGGTGK KSTNSRFENY GDKFAENDVI GCFADFECGN DVELSFTKNG KWMGIAFRIQ
370 380 390 400 410 420
KEALGGQALY PHVLVKNCAV EFNFGQRAEP YCSVLPGFTF IQHLPLSERI RGTIGPKSKA
430 440 450 460 470 480
ECEILMMVGL PAAGKTTWAI KHAASNPSKK YNILGTNAIM DKMRVMGLRR QRNYAGRWDV
490 500 510 520 530 540
LIQQATQCLN RLIQIAARKK RNYILDQTNV YGSAQRRKMR PFEGFQRKAI VICPTDEDLK
550 560 570 580 590 600
DRTVKRTDEE GKDVPDHAVL EMKANFTLPD VGDFLDEVLF IELQREEADK LVRQYNEEGR
610 620 630 640 650 660
KAGPPPEKRF DSRGGGFRGR GGGGGFQRYD NRGPPGGNRG GFQNRGGGGG SGGGGGNYRG
670 680 690 700 710 720
GFNRSGGGGY NQNRWGNNNR DNNNSNNRGN YNRAPQQQPP PQQPPPPQPP PQQPPPPPSY
730 740 750 760 770 780
SPARNPPGAS SYNKNSNIPG SSANTSTPTV SSYTPPQPSY SQPPYNQGGY TQGYTAPPPP
790 800 810 820 830 840
PPPPPAYNYG SYGPYNPAPY TPPPPPTAQT YPQPSYNQYQ QYAQQWSQYY QNQSQWPPYY
850
GNYDYGGYSG STQGGTSTQ